The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
Daniel M. Green(St. Jude Children's Research Hospital), Leslie L. Robison(St. Jude Children's Research Hospital), Lisa Diller(Dana-Farber Cancer Institute), Deo Kumar Srivastava(St. Jude Children's Research Hospital), Pamela J. Goodman(Fred Hutch Cancer Center), John Whitton(Fred Hutch Cancer Center), Charles A. Sklar(Memorial Sloan Kettering Cancer Center), Wendy M. Leisenring(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joseph P. Neglia(University of Minnesota), Marilyn Stovall(The University of Texas MD Anderson Cancer Center), Melissa M. Hudson(St. Jude Children's Research Hospital), Val Nolan(University of Memphis), Sue C. Kaste(St. Jude Children's Research Hospital), Sarah S. Donaldson(Washington University in St. Louis)
Cited by 459
Related Papers
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2017|1.3k
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
|Nature reviews. Cancer|2013|864